PLEASANTON, California, June 16, 2015 /PRNewswire/ -- Unchained Labs, a refreshingly new biologics tools company, UNleashed the HUNK today, the world's first quantitative biologics stability predictor. The HUNK gives drug discovery scientists up-front insight on the stability of their protein formulations with information on how and if the safety and efficacy of their biologic will be affected during storage.
In a nutshell, the HUNK measures a time-tested thermodynamic value, ΔG, using chemical denaturation. This lets researchers determine if their protein will stay stable or aggregate over time. The kicker? The HUNK also tells them if their protein aggregates from the native or denatured state — something that can't be done with any other tool today. Knowing which type of aggregation is the culprit gives scientists an immediate understanding of which corrective action to take. The HUNK also automates the complex sample prep and analysis process, making these once complicated and time-intensive measurements completely routine.
"The HUNK takes our biologics stability tools line up to the next level," said Taegen Clary, Sr. Director of Marketing at Unchained Labs. "It UNlocks completely new and quantitative information about how proteins aggregate, and lets scientists visualize future stability in an entirely new way."
About Unchained Labs
Unchained Labs is committed to building the first cool biologics tools company. One that matters. One without old school rules. One with products that'll make a real difference in the research scientists do every day. We plan to buy businesses and product lines and then add our magic touch for developing breakthrough products and selling them like crazy. We are located in Pleasanton, CA and can be found online at www.unchainedlabs.com.
Contact: Taegen Clary, Senior Director of Marketing, Unchained Labs, email@example.com, +1.925.587.9806
SOURCE Unchained Labs